Salveen Richter
Stock Analyst at Goldman Sachs
(3.54)
# 836
Out of 5,140 analysts
207
Total ratings
44.35%
Success rate
7.48%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Neutral | $36 → $41 | $49.87 | -17.79% | 11 | Feb 17, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $29.25 | -14.53% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.34 | -23.29% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $23.43 | +62.19% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $18.99 | -15.75% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $83.15 | -21.83% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $22.28 | -19.21% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $21.50 | +20.93% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $336.19 | +68.36% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $9.02 | +321.29% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $18.88 | +0.64% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $23.99 | -29.14% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $26.02 | +42.20% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $53.46 | -12.08% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $64.08 | +62.30% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $15.94 | +157.21% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $15.20 | -34.21% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $779.67 | +3.12% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $192.03 | +2.59% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.70 | +106.90% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $151.40 | -36.59% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $20.19 | +98.12% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $12.64 | -5.06% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $96.47 | -25.37% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $101.32 | -30.91% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $22.72 | +234.51% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $374.75 | -6.60% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $476.90 | +17.22% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $24.50 | -79.59% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.05 | +1,412.20% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $226.98 | -0.87% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.27 | +572.78% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.40 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $3.79 | +691.56% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.42 | +163.16% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.70 | -36.17% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.01 | +49.63% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $75.73 | -43.22% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $3.90 | -48.72% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $4.18 | +2,292.34% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $8.61 | +6,868.64% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $128.46 | -61.08% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $63.59 | -29.23% | 1 | Mar 17, 2020 |
Moderna
Feb 17, 2026
Maintains: Neutral
Price Target: $36 → $41
Current: $49.87
Upside: -17.79%
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $29.25
Upside: -14.53%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.34
Upside: -23.29%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $23.43
Upside: +62.19%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $18.99
Upside: -15.75%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $83.15
Upside: -21.83%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $22.28
Upside: -19.21%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $21.50
Upside: +20.93%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $336.19
Upside: +68.36%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $9.02
Upside: +321.29%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $18.88
Upside: +0.64%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $23.99
Upside: -29.14%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $26.02
Upside: +42.20%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $53.46
Upside: -12.08%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $64.08
Upside: +62.30%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $15.94
Upside: +157.21%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $15.20
Upside: -34.21%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $779.67
Upside: +3.12%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $192.03
Upside: +2.59%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.70
Upside: +106.90%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $151.40
Upside: -36.59%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $20.19
Upside: +98.12%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $12.64
Upside: -5.06%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $96.47
Upside: -25.37%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $101.32
Upside: -30.91%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $22.72
Upside: +234.51%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $374.75
Upside: -6.60%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $476.90
Upside: +17.22%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $24.50
Upside: -79.59%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.05
Upside: +1,412.20%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $226.98
Upside: -0.87%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.27
Upside: +572.78%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.40
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $3.79
Upside: +691.56%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.42
Upside: +163.16%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.70
Upside: -36.17%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.01
Upside: +49.63%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $75.73
Upside: -43.22%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $3.90
Upside: -48.72%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $4.18
Upside: +2,292.34%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $8.61
Upside: +6,868.64%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $128.46
Upside: -61.08%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $63.59
Upside: -29.23%